VEGF Inhibition in NSCLC
4:24
VEGF Inhibition in NSCLC
144 viewsAug 1, 2018
YouTubeAJMCtv MJH
Combining EGFR and VEGF inhibitors for NSCLC
2:27
Combining EGFR and VEGF inhibitors for NSCLC
408 viewsApr 19, 2021
YouTubeVJOncology
Dual Checkpoint Inhibitor Therapy for NSCLC | OncLive
Dual Checkpoint Inhibitor Therapy for NSCLC | OncLive
Mar 1, 2018
onclive.com
Selecting a First-Line EGFR Inhibitor in NSCLC | OncLive
Selecting a First-Line EGFR Inhibitor in NSCLC | OncLive
Aug 21, 2013
onclive.com
NSCLC: Integrating EGFR-Inhibiting Therapies into Clinical Pathways for First-Line Treatment
37:23
NSCLC: Integrating EGFR-Inhibiting Therapies into Clinical Pathways f…
7.5K viewsFeb 20, 2019
YouTubeHMP Education
Novel EGFR Inhibitor Combinations for NSCLC | OncLive
Novel EGFR Inhibitor Combinations for NSCLC | OncLive
Jul 19, 2019
onclive.com
Reconsideration of Gefitinib in EGFR-Mutant NSCLC | OncLive
Reconsideration of Gefitinib in EGFR-Mutant NSCLC | OncLive
Nov 20, 2014
onclive.com
Overcoming EGFR Inhibitor Resistance in NSCLC | OncLive
Feb 27, 2015
onclive.com
1:18
Rechallenging with immunotherapy in 2L NSCLC remains difficult.As …
1.4K views1 month ago
x.comInternational Lung Cancer Summit
Guideline recommendations for first-line treatment of advanced N…
Nov 26, 2024
reachmd.com
The Ever-Evolving Treatment Paradigm for NSCLC | OncLive
Jul 13, 2017
onclive.com
6:18
Treating NSCLC With Ramucirumab: The REVEL Trial
855 viewsApr 25, 2018
YouTubeOncLive
Immuno-Oncology Combination Therapy in NSCLC | OncLive
Sep 28, 2017
onclive.com
NSCLC Immunotherapy: Transformation of Upfront Therap…
Sep 28, 2017
onclive.com
5:48
EGFR-Mutated NSCLC: Treatment Options Following Progression o…
Oct 19, 2023
onclive.com
Navigating TKI Selection in HER2-Mutant NSCLC | OncLive
3 weeks ago
onclive.com
3:46
Patient Selection for Frontline Bevacizumab in NSCLC
176 viewsApr 20, 2018
YouTubeOncLive
EGFR Mutations in NSCLC: Clinical Use and Implications of Amivanta…
7 months ago
vumedi.com
EGFR-mutated NSCLC: Evolving Treatment Landscape | OncLive
10 months ago
onclive.com
Novel Immunotherapy Combinations for NSCLC | OncLive
Jul 13, 2017
onclive.com
Dr. Konduri on Treatment Options for Patients With EGFR-Mutant NS…
Apr 24, 2019
onclive.com
Guidelines-recommended targeted therapies as second-line treatmen…
Nov 26, 2024
reachmd.com
KRAS G12C-Mutated NSCLC: Current Treatment Paradigms | On…
10 months ago
onclive.com
Dr Skoulidis on the Methods of Analyzing KRAS G12C Inhibitor Ef…
May 23, 2023
onclive.com
BRIGHTSTAR: Local Consolidative Therapy with Brigatinib in Tyrosin…
Oct 6, 2023
onclive.com
Combination Therapy: A New Frontline Standard in the Treatme…
11 months ago
onclive.com
1:47
EGFR Inhibitors in Development for NSCLC
90 viewsOct 23, 2018
YouTubeOncLive
Immunotherapy for Management of Stage 3B NSCLC | OncLive
Sep 28, 2017
onclive.com
Rationale Behind Antiangiogenic Therapy in NSCLC | OncLive
Apr 19, 2018
onclive.com
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Dec 28, 2023
reachmd.com
See more videos
Static thumbnail place holder